Topics

Codiak Biosciences Lines up for $86 Million IPO

20:00 EDT 30 Apr 2019 | BioSpace

The company is banking on investors approving of its approach to harness exosomes, which had once been considered the cells’ garbage cans, as a means of pioneering a new class of biologic medicines.

Original Article: Codiak Biosciences Lines up for $86 Million IPO

NEXT ARTICLE

More From BioPortfolio on "Codiak Biosciences Lines up for $86 Million IPO"

Quick Search